Business Description
Thai Nakarin Hospital PCL
SIC : 8060
ISIN : TH0883010017
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.87 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 11.71 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6 | |||||
3-Year EBITDA Growth Rate | 13 | |||||
3-Year EPS without NRI Growth Rate | 11.2 | |||||
3-Year FCF Growth Rate | 12.9 | |||||
3-Year Book Growth Rate | 12.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.69 | |||||
Quick Ratio | 5.57 | |||||
Cash Ratio | 4.92 | |||||
Days Inventory | 7.47 | |||||
Days Sales Outstanding | 28.68 | |||||
Days Payable | 20.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 2.9 | |||||
Shareholder Yield % | 1.68 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.04 | |||||
Operating Margin % | 20.09 | |||||
Net Margin % | 16.75 | |||||
FCF Margin % | 15.26 | |||||
ROE % | 15.65 | |||||
ROA % | 13.41 | |||||
ROIC % | 27.38 | |||||
3-Year ROIIC % | 27.66 | |||||
ROC (Joel Greenblatt) % | 38.52 | |||||
ROCE % | 18.07 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.71 | |||||
PE Ratio without NRI | 14.71 | |||||
Shiller PE Ratio | 17.28 | |||||
Price-to-Owner-Earnings | 14.71 | |||||
PEG Ratio | 3.27 | |||||
PS Ratio | 2.45 | |||||
PB Ratio | 2.18 | |||||
Price-to-Tangible-Book | 2.19 | |||||
Price-to-Free-Cash-Flow | 16.07 | |||||
Price-to-Operating-Cash-Flow | 11.04 | |||||
EV-to-EBIT | 9.16 | |||||
EV-to-EBITDA | 7.43 | |||||
EV-to-Revenue | 1.84 | |||||
EV-to-FCF | 12.05 | |||||
Price-to-Projected-FCF | 1.52 | |||||
Price-to-DCF (Earnings Based) | 0.33 | |||||
Price-to-DCF (FCF Based) | 0.25 | |||||
Price-to-Median-PS-Value | 0.87 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.5 | |||||
Price-to-Graham-Number | 1.2 | |||||
Price-to-Net-Current-Asset-Value | 4.52 | |||||
Price-to-Net-Cash | 5.51 | |||||
Earnings Yield (Greenblatt) % | 10.92 | |||||
FCF Yield % | 6.22 | |||||
Forward Rate of Return (Yacktman) % | 12.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Thai Nakarin Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ฿) | 2,623.61 | ||
EPS (TTM) (฿) | 2.43 | ||
Beta | 0.15 | ||
Volatility % | 5.08 | ||
14-Day RSI | 0 | ||
14-Day ATR (฿) | 0 | ||
20-Day SMA (฿) | 11.8 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (฿) | 11.8 - 11.8 | ||
Shares Outstanding (Mil) | 180 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Thai Nakarin Hospital PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Thai Nakarin Hospital PCL Stock Events
Event | Date | Price(฿) | ||
---|---|---|---|---|
No Event Data |
Thai Nakarin Hospital PCL Frequently Asked Questions
What is Thai Nakarin Hospital PCL(BKK:TNH-F)'s stock price today?
When is next earnings date of Thai Nakarin Hospital PCL(BKK:TNH-F)?
Does Thai Nakarin Hospital PCL(BKK:TNH-F) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |